ProSomnus, Inc.

Equities

OSAP.Q

US50535E1082

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 03:32:23 2024-06-14 pm EDT			5-day change	1st Jan Change
0.01 ^USD	-60.00%		-66.67%	-98.98%

May. 24	Joint Reorganization Plan and Disclosure Statement Filed by ProSomnus, Inc.	CI
May. 20	ProSomnus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

ProSomnus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024

May 20, 2024 at 04:35 pm EDT

ProSomnus, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 7.46 million compared to USD 5.81 million a year ago. Net income was USD 3.44 million compared to net loss of USD 6.89 million a year ago.

Basic earnings per share from continuing operations was USD 0.2 compared to basic loss per share from continuing operations of USD 0.43 a year ago. Diluted loss per share from continuing operations was USD 0.02 compared to USD 0.43 a year ago.

Latest news about ProSomnus, Inc.

Joint Reorganization Plan and Disclosure Statement Filed by ProSomnus, Inc.	May. 24	CI
ProSomnus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 20	CI
Prosomnus Contributes Two Scientific Abstracts Accepted for Presentation At the 2024 American Academy of Dental Sleep Medicine Annual Meeting	May. 13	CI
Interim DIP Financing Approved for ProSomnus, Inc.	May. 09	CI
Motion for Joint Administration Approved for ProSomnus, Inc.	May. 09	CI
Motion for Joint Administration Filed by ProSomnus, Inc.	May. 07	CI
ProSomnus, Inc. Filed for Bankruptcy	May. 07	CI
ProSomnus, Inc.(OTCPK:OSAP) dropped from S&P TMI Index	Apr. 21	CI
ProSomnus, Inc. announced that it has received $2 million in funding	Apr. 16	CI
ProSomnus, Inc.(OTCPK:OSAP) dropped from NASDAQ Composite Index	Apr. 16	CI
Transcript : ProSomnus, Inc., Q4 2023 Earnings Call, Mar 26, 2024	Mar. 26
ProSomnus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
ProSomnus, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 26	CI
Prosomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea	Feb. 22	CI
ProSomnus, Inc. Severe Indication 510(K) Submission Accepts for Review by the Fda	Jan. 30	CI
Top Midday Gainers	Dec. 19	MT
Craig-Hallum Downgrades ProSomnus to Hold From Buy, Cuts Price Target to $1 From $10	Nov. 10	MT
ProSomnus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Transcript : ProSomnus, Inc., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
Earnings Flash (OSA) PROSOMNUS SLEEP TECHNOLOGIES Posts Q3 Revenue $7.1M, vs. Street Est of $7.03M	Nov. 09	MT
Roth MKM Cuts Price Target on ProSomnus to $4 From $6, Maintains Buy Rating	23-09-26	MT
ProSomnus, Inc. announced that it expects to receive $25 million in funding from Spring Mountain Capital, LP and other investors	23-09-19	CI
Prosomnus, Inc. Announces Updated Clinical Trial Data	23-08-23	CI
Transcript : ProSomnus, Inc., Q2 2023 Earnings Call, Aug 03, 2023	23-08-03
ProSomnus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03	CI

Chart ProSomnus, Inc.

Duration

Period

More charts

Company Profile

ProSomnus, Inc. is a medical technology company. The Company is focused on the development, manufacturing and marketing of precision intraoral medical devices, a novel non-invasive option for treating and managing patients with obstructive sleep apnea (OSA). Its intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient. The Company's devices have demonstrated efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. Its precision intraoral devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, TRICARE and many Government-sponsored healthcare plans around the world, representing over 200 million covered lives. The Companyâs products include ProSomnus EVO Sleep and Snore Device, ProSomnus EVO SELECT Sleep and Snore Device, ProSomnus EVO [PH] Sleep and Snore Device, ProSomnus [CA] LP Sleep and Snore Device and ProSomnus [MOG] Morning Occlusal Guide.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-31 - Q2 2024 Earnings Release (Projected)

More about the company